{
    "title": "109_hr3423",
    "content": "The Act may be cited as the \"Medical Device User Fee Stabilization Act of 2005\" and includes amendments to the Federal Food, Drug, and Cosmetic Act. The Medical Device User Fee Stabilization Act of 2005 amends the Federal Food, Drug, and Cosmetic Act by adjusting device user fees and annual fee setting procedures. The Medical Device User Fee Stabilization Act of 2005 amends the Federal Food, Drug, and Cosmetic Act by adjusting device user fees and annual fee setting procedures. The amendments include redesignating paragraphs, updating fee amounts for fiscal years, and specifying the process for publishing fees in the Federal Register. The Medical Device User Fee Stabilization Act of 2005 adjusts device user fees for fiscal years 2006 and 2007, allowing the Secretary to use unobligated carryover balances to ensure fee revenues are available. The Medical Device User Fee Stabilization Act of 2005 allows the Secretary to use unobligated carryover balances to ensure fee revenues are available for fiscal years 2006 and 2007. The Act also requires the Secretary to provide notice to specific congressional committees before using the funds described in the Act. In subsection (d), the definition of \"small business\" is revised to include entities with $30,000,000 or less in gross receipts or sales. Additionally, the threshold for this definition is increased to $100,000,000 in paragraph 2(A). In subsection (d), the definition of \"small business\" is revised to include entities with $30,000,000 or less in gross receipts or sales. The threshold for this definition is increased to $100,000,000 in paragraph 2(A). Additionally, amendments are made to subsections (e)(2)(A) and (g)(1) to reflect the changes in financial thresholds. The fiscal year's performance goals must be met if the appropriated amount is equal to or greater than $205,720,000 multiplied by the adjustment factor for that year. If the appropriated amount for the fiscal year is more than 1 percent less than the specified amount, certain conditions apply. The specified amount for the fiscal year is adjusted by striking \"2003 through\" and inserting \"2005 and\", and by inserting \"more than 1 percent\" after \"years, is\". In subsection (h)(3), subparagraphs (D) and (E) are replaced with necessary sums for fiscal years 2006 and 2007. Additionally, \"subsection (c)(5)\" is changed to \"subsection (c)(1)\" throughout the text. The text amends Section 103 of the Medical Device User Fee and Modernization Act of 2002 by changing \"subsection (c)(5)\" to \"subsection (c)(1)\" and adding requirements for annual reports for fiscal years 2006 and 2007. The text requires annual reports on fees paid by businesses for different types of applications and notifications, categorized by gross receipts intervals. It also includes a certification by the Secretary on the appropriation of funds for FDA salaries and expenses related to device functions. The text outlines the review process for device applications and the requirements for reprocessed single-use devices under the Federal Food, Drug, and Cosmetic Act. Reprocessed devices must bear manufacturer's name, abbreviation, or symbol prominently. If original device lacks manufacturer's identification, a detachable label on packaging can fulfill this requirement. The Secretary of Health and Human Services will issue guidance within 180 days to determine when the manufacturer's name, abbreviation, or symbol on reprocessed medical devices is not considered prominent and conspicuous. The manufacturer's symbol must be prominent and conspicuous on medical devices, as required by the Federal Food, Drug, and Cosmetic Act. The effective date for this requirement is specified in the Medical Device User Fee and Modernization Act of 2002. The Fee Stabilization Act of 2005 specifies the effective dates for the manufacturer's symbol requirement on medical devices. The Fee Stabilization Act of 2005 sets effective dates for the manufacturer's symbol requirement on medical devices, including devices reprocessed and introduced in interstate commerce. The curr_chunk is about the roles of the Speaker of the House of Representatives and the Vice President of the United States as President of the Senate."
}